Ronald Landbloom

826 total citations
15 papers, 598 citations indexed

About

Ronald Landbloom is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Ronald Landbloom has authored 15 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 4 papers in Cognitive Neuroscience. Recurrent topics in Ronald Landbloom's work include Schizophrenia research and treatment (6 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Electroconvulsive Therapy Studies (3 papers). Ronald Landbloom is often cited by papers focused on Schizophrenia research and treatment (6 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Electroconvulsive Therapy Studies (3 papers). Ronald Landbloom collaborates with scholars based in United States, India and Canada. Ronald Landbloom's co-authors include Eduardo Dunayevich, Louise R. Levine, Martin Marciniak, Maureen J. Lage, Gary D. Tollefson, J. Erickson, Darryle D. Schoepp, James M. Russell, Lee Bowman and Mary Mackle and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Ronald Landbloom

15 papers receiving 576 citations

Peers

Countries citing papers authored by Ronald Landbloom

Since Specialization

Citations

This map shows the geographic impact of Ronald Landbloom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Landbloom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Landbloom more than expected).

Fields of papers citing papers by Ronald Landbloom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Landbloom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Landbloom. The network helps show where Ronald Landbloom may publish in the future.

Co-authorship network of co-authors of Ronald Landbloom

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Landbloom. A scholar is included among the top collaborators of Ronald Landbloom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Landbloom. Ronald Landbloom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder 2017 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Ronald Landbloom, Cheng‐Tao Chang, Willie Earley	10
2	Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study 2017 ·Neuropsychiatric Disease and Treatment ·Suresh Durgam, Ronald Landbloom, Mary Mackle, (unknown), Maju Mathews, Henry A. Nasrallah	8
3	Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder 2017 ·American Journal of Psychiatry ·Armin Szegedi, Suresh Durgam, Mary Mackle, Sung Yun Yu, (unknown), Maju Mathews, Ronald Landbloom	27
4	Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control 2016 ·CNS Spectrums ·Ronald Landbloom, Mary Mackle, (unknown), Linda Kelly, (unknown), Roger S. McIntyre, Maju Mathews, (unknown)	23
5	Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder 2016 ·Journal of Affective Disorders ·Terence A. Ketter, Suresh Durgam, Ronald Landbloom, Mary Mackle, (unknown), Maju Mathews	7
6	Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia 2015 ·Journal of Child and Adolescent Psychopharmacology ·Robert L. Findling, Ronald Landbloom, Mary Mackle, (unknown), Sabine Braat, (unknown), Marianne Z. Wamboldt, Maju Mathews	32
7	Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder 2013 ·The Primary Care Companion For CNS Disorders ·Susan L. McElroy, Anna I. Guerdjikova, Dennis Dong Hwan Kim, Colleen Burns, (unknown), Ronald Landbloom, Eduardo Dunayevich	33
8	Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder 2013 ·The Journal of Clinical Psychiatry ·David E. Kemp, Jun Zhao, Pilar Cazorla, Ronald Landbloom, Mary Mackle, (unknown), Armin Szegedi	23
9	Zonisamide Prevents Olanzapine-Associated Hyperphagia, Weight Gain, and Elevated Blood Glucose in Rats 2008 ·Neuropsychopharmacology ·(unknown), Puspha Sinnayah, Frank P. Bymaster, Kishore M. Gadde, (unknown), (unknown), Ronald Landbloom, Gary D. Tollefson, Michael A. Cowley	36
10	Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post‐hoc analysis 2007 ·International Journal of Geriatric Psychiatry ·Walter Deberdt, Alan P. Siegal, Jonna Ahl, Adam L. Meyers, Ronald Landbloom	8
11	Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder 2007 ·Neuropsychopharmacology ·Eduardo Dunayevich, J. Erickson, Louise R. Levine, Ronald Landbloom, Darryle D. Schoepp, Gary D. Tollefson	147
12	The cost of treating anxiety: the medical and demographic correlates that impact total medical costs 2005 ·Depression and Anxiety ·Martin Marciniak, Maureen J. Lage, Eduardo Dunayevich, James M. Russell, Lee Bowman, Ronald Landbloom, Louise R. Levine	141
13	Medical and productivity costs of anxiety disorders: Case control study 2004 ·Depression and Anxiety ·Martin Marciniak, Maureen J. Lage, Ronald Landbloom, Eduardo Dunayevich, Lee Bowman	70
14	Fluvoxamine for children and adolescents with Obsessive Compulsive Disorder: A controlled multicenter trial 1996 ·European Neuropsychopharmacology ·Mark A. Riddle, James L. Claghorn, Gary Gaffney, John H. Greist, (unknown), Ronald Landbloom, B.J. Mcconville, (unknown), (unknown), John T. Walkup, (unknown), Vincent P. Houser	14
15	A controlled trial of fluvoxamine for OCD in children and adolescents 1996 ·Biological Psychiatry ·Mark A. Riddle, James L. Claghorn, Gary Gaffney, John H. Greist, (unknown), Ronald Landbloom, B.J. Mcconville, Teresa A. Pigott, (unknown), John T. Walkup, José A. Yaryura-Tobias, Vincent P. Houser	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact